Zobrazeno 1 - 10
of 15
pro vyhledávání: '"Gianfranco Mancuso"'
Autor:
Piera Gargiulo, Laura Arenare, Cesare Gridelli, Alessandro Morabito, Fortunato Ciardiello, Vittorio Gebbia, Paolo Maione, Alessia Spagnuolo, Giuliano Palumbo, Giovanna Esposito, Carminia Maria Della Corte, Floriana Morgillo, Gianfranco Mancuso, Raimondo Di Liello, Adriano Gravina, Clorinda Schettino, Massimo Di Maio, Ciro Gallo, Francesco Perrone, Maria Carmela Piccirillo
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
Abstract Background Chemotherapy-induced neutropenia (CIN) has been demonstrated to be a prognostic factor in several cancer conditions. We previously found a significant prognostic value of CIN on overall survival (OS), in a pooled dataset of patien
Externí odkaz:
https://doaj.org/article/a4ff3976bddf475882f1ba7ca7d1a374
Autor:
Alberto Firenze, Livio Blasi, Francesco Verderame, Alba La Sala, I. Fazio, Sergio Rizzo, Hector Soto-parra, Gianluca Mortillaro, Roberto Marchese, Maurizio Chiarenza, Giuseppe Agneta, M. Spada, Dario Piazza, Enrico Potenza, Helga Lipari, M. R. Valerio, Concetta Sergi, Sergio Baldari, Amato C, Alfio Di Grazia, F. Ferraù, Alessandro Bertani, Elena Roz, Vittorio Gebbia, Gianfranco Mancuso, A. Guarini
Publikováno v:
Pulmonary Therapy
To date, the virtual multidisciplinary tumor boards (vMTBs) are increasingly used to achieve high-quality treatment recommendations across health-care regions, which expands and develops the local MTB team to a regional or national expert network. Th
Autor:
Floriana Morgillo, Giovanna Esposito, Gianfranco Mancuso, Francesco Perrone, Fortunato Ciardiello, Maria Carmela Piccirillo, Paolo Maione, Clorinda Schettino, Cesare Gridelli, Raimondo Di Liello, Piera Gargiulo, Vittorio Gebbia, Giuliano Palumbo, Massimo Di Maio, Adriano Gravina, Alessia Spagnuolo, Laura Arenare, Alessandro Morabito, Carminia Maria Della Corte, Ciro Gallo
Publikováno v:
BMC Cancer, Vol 21, Iss 1, Pp 1-9 (2021)
BMC Cancer
BMC Cancer
Background Chemotherapy-induced neutropenia (CIN) has been demonstrated to be a prognostic factor in several cancer conditions. We previously found a significant prognostic value of CIN on overall survival (OS), in a pooled dataset of patients with a
Autor:
Paolo Vigneri, Giuseppe Luigi Banna, Dariio Giuffrida, Maria Rosaria Valerio, Nicolò Borsellino, Vittorio Gebbia, Dario Piazza, Mario Lo Mauro, Hector Soto Parra, Gianfranco Mancuso, Giusi Blanco, Francesco Verderame, Livio Blasi, Giuseppina Savio, Marco Aiello
Publikováno v:
ecancermedicalscience
Purpose The availability of immune checkpoint inhibitors has deeply changed the therapeutic scenario of patients with advanced non-small cell lung cancer (NSCLC). Up until now, chemotherapy still represents the first-line treatment for patients with
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::290ca920411a1c49f4ffd8f2db90379d
http://hdl.handle.net/10447/438590
http://hdl.handle.net/10447/438590
Autor:
Antonio Pontoriero, Maria Rosaria Valerio, Nicolò Borsellino, A. Girlando, Mariacarmela Santarpia, Giuseppe Altavilla, Stefano Pergolizzi, Dario Piazza, Gianfranco Mancuso, Vittorio Gebbia
Publikováno v:
In Vivo
Background/aim Local ablative treatments for oligo-progressive, EGFR mutated non-small cell lung cancer (mut-NCSLC) may improve long-term disease control and survival. We analyzed the efficacy of hypo-fractionated, high-dose radiation therapy (HDRT),
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7d4fc334f8d7e229c8822f9c0461423b
http://hdl.handle.net/11570/3209459
http://hdl.handle.net/11570/3209459
Autor:
R. Di Liello, Ciro Gallo, Alessia Spagnuolo, M. Di Maio, Mauro Piccirillo, Francesco Perrone, C. Gridelli, C.M. Della Corte, Fortunato Ciardiello, Adriano Gravina, Clorinda Schettino, Vittorio Gebbia, Alessandro Morabito, Piera Gargiulo, Gianfranco Mancuso, Floriana Morgillo, P. Maione, Laura Arenare, Grazia Esposito, Giuliano Palumbo
Publikováno v:
Journal of Thoracic Oncology. 16:S789-S790
Autor:
A. Girlando, Gianfranco Mancuso, Giuseppe Altavilla, Mariacarmela Santarpia, Vittorio Gebbia, Nicolò Borsellino, Maria Rosaria Valerio
Publikováno v:
Journal of Clinical Oncology. 38:e21580-e21580
e21580 Background: EGFR tyrosine kinase inhibitors (TKIs) represent the standard first-line therapy for advanced non-small cell lung cancer (NSCLC) patients with activating EGFR mutations. However, despite initial marked responses, tumors invariably
Autor:
Antonio Rossi, Umberto Malapelle, Lorenza Landi, Giampiero Romano, Michele Montrone, Tindara Franchina, Alessandro Morabito, Elisa Roca, Paola Mazzanti, Alessandra Bulotta, Roberto Bianco, Sara Pilotto, Lucio Buffoni, Barbara Melotti, Vito Barbieri, C.Y. Finocchiaro, Annamaria Carta, Lorenzo Piccolo, Gianfranco Mancuso, Vincenzo Minotti, Ivano Boscardini, Raffaele Costanzo, Romano Danesi, Alessandro Del Conte, Alessandra Rota, Gloria Borra, Giuseppa Savio, Vanesa Gregorc, Olga Martelli, Luciana Irtelli, Marcello Tiseo, Antonio Cusmai, Diego Cortinovis, Maria Rita Migliorino, Marina Gilli, Anna Cecilia Bettini, Francesco Malorgio, Ettore D'Argento
Publikováno v:
Translational Cancer Research
Background: In the field of oncological assistance, nowadays we have to deal with a complex scenario where patients got used to obtain a huge amount of information through internet or social media and to apply them in performing their health-related
Autor:
Nicolò Borsellino, F. Riccardi, Michele Caruso M, Vittorio Gebbia, Francesco Carrozza, Saverio Cinieri, Silvana Leo, Gianfranco Mancuso, F. Ferraù, Giuseppe Colucci, Domenico Galetta, S. Mancarella, Vito Lorusso, G. Palomba
Publikováno v:
Lung Cancer. 69:218-224
Background Quality of life (QoL) has gained greater importance in the management of metastatic non-small-cell lung cancer due to the palliative nature of treatment. Docetaxel (DCT) and cisplatin (CDDP) doublet has been reported to be associated to a
Autor:
Massimo Di Maio, Cesare Gridelli, Teresa Gamucci, Francesco Perrone, Vittorio Gebbia, Bruno Daniele, Claudio Verusio, Luciano Frontini, Enrico Aitini, Gianfranco Mancuso, Ciro Gallo, Alessandro Morabito
Publikováno v:
Lung Cancer. 63:251-258
Background Doublet chemotherapy is more effective than single-agent as first line treatment of advanced non-small-cell lung cancer (NSCLC). No reliable information instead is available on the effect of doublets in second line treatment. The aim of DI